Impact of M22 Synergistic Sequential Treatment (SST)

NCT02032771 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Improvement of Wrinkles/Elastosis and/or Pigmentation

Interventions

DEVICE: M22 IPL and ResurFX

Sponsor

Lumenis Be Ltd.